Medications for anxiety
Pro Research Analysisby 
Searched over 200M research papers
First-Line Medications for Anxiety Disorders: SSRIs and SNRIs
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are widely recognized as the first-line medications for treating anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder. These medications are effective for most patients and are recommended by major treatment guidelines and expert panels worldwide 1234+2 MORE. SSRIs and SNRIs are preferred because of their efficacy and relatively favorable side effect profiles compared to older medications.
Other Pharmacological Options: Benzodiazepines, Buspirone, and More
Benzodiazepines can be effective for acute anxiety but are not recommended for long-term or routine use due to risks of dependence, cognitive impairment, and withdrawal symptoms 1346+1 MORE. Other medications sometimes used include:
- Buspirone: An azapirone anxiolytic, mainly prescribed for GAD, with a lower risk of dependence but generally less effective than SSRIs/SNRIs 2346.
- Pregabalin and Gabapentin: These calcium channel modulators are sometimes used for GAD and have shown some benefit 1267.
- Tricyclic Antidepressants and Monoamine Oxidase Inhibitors (MAOIs): These are generally reserved for cases where first-line treatments are ineffective due to their side effect profiles 147.
- Other Agents: Medications such as hydroxyzine (an antihistamine), propranolol and clonidine (adrenergic agents), and quetiapine (an atypical antipsychotic) may be used in specific situations or as adjuncts 26.
Duration and Combination with Psychotherapy
Medication for anxiety disorders is typically continued for 6 to 12 months after remission to prevent relapse 17. Combining medication with psychological therapies, especially cognitive behavioral therapy (CBT), often leads to better outcomes than either approach alone 1710.
Novel and Emerging Treatments for Anxiety
There is growing interest in developing new medications for anxiety disorders, especially for patients who do not respond to current treatments. Research is exploring drugs that target different neurotransmitter systems, such as:
- Glutamate Modulators: Agents like ketamine, riluzole, and xenon are being studied for their potential to modulate glutamatergic neurotransmission and reduce anxiety 2589.
- Neuropeptides and Neurosteroids: Compounds like aloradine and PH94B (an inhaled neurosteroid) are under investigation 259.
- Cannabinoids: Cannabidiol (CBD) and other cannabinoids are being tested, though results are mixed so far 259.
- Other Novel Agents: D-cycloserine, MDMA, and L-DOPA are being studied as adjuncts to psychotherapy to enhance fear extinction and improve long-term outcomes 59.
Despite these advances, most novel treatments are still in early stages, and more large-scale studies are needed to confirm their effectiveness 2589.
Considerations for Medication Choice
When choosing a medication for anxiety, clinicians consider factors such as efficacy, side effects, potential drug interactions, cost, and patient preferences 1710. The goal is to find a treatment that is both effective and well-tolerated for the individual patient.
Conclusion
SSRIs and SNRIs remain the mainstay of pharmacological treatment for anxiety disorders, with other options available for specific cases or when first-line treatments are not effective. Benzodiazepines are generally avoided for long-term use due to safety concerns. Research into novel medications is ongoing, with promising new targets being explored, but more evidence is needed before these become standard treatments. Combining medication with psychotherapy, especially CBT, often provides the best results for managing anxiety disorders 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic